Intra-Cellular Therapies Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	164.78	580.68
Short-Term Investments	7	7
Cash & Short-Term Investments	171.78	587.68
Cash Growth	-70.77%	-
Other Receivables	9.58	7.77
Receivables	25.69	33.59
Prepaid Expenses	0.04	0.17
Other Current Assets	92.77	213.02
Total Current Assets	290.28	834.45
Property, Plant & Equipment	51.38	77.04
Long-Term Investments	1.6	17.62
Goodwill	54.34	74.72
Other Intangible Assets	319.07	37.56
Other Long-Term Assets	41.15	41.15
Total Assets	757.83	1,083
Accrued Expenses	29.84	15.59
Short-Term Debt	708.74	-
Current Portion of Long-Term Debt	331.77	-
Other Current Liabilities	108.03	7.39
Total Current Liabilities	1,178	22.98
Long-Term Debt	1,809	2,013
Other Long-Term Liabilities	0	0
Total Liabilities	3,025	2,155
Common Stock	520.07	520.07
Additional Paid-In Capital	600.34	600.34
Retained Earnings	-3,388	-2,192
Comprehensive Income & Other	-0	-
Shareholders' Equity	-2,267	-1,072
Total Liabilities & Equity	757.83	1,083
Total Debt	2,849	2,013
Net Cash (Debt)	-2,678	-1,426
Net Cash Per Share	-25720.38	-13695.70
Filing Date Shares Outstanding	0.1	0.1
Total Common Shares Outstanding	0.1	0.1
Working Capital	-888.1	811.47
Book Value Per Share	-21779.25	-10297.33
Tangible Book Value	-2,641	-1,184
Tangible Book Value Per Share	-25366.05	-11375.85
Machinery	98.64	98.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.